biologics

Security of biomanufacturing infrastructures

security of biomanufacturing

I am glad to be part of a multi-institutional team newly commissioned to analyze the security of biomanufacturing infrastructures.  Facilities that manufacture biologic drugs like vaccines are a critical part of the nation’s biodefense infrastructure. Possible breaches of data systems controlling these biomanufacturing supply chains call for an assessment of their vulnerability to cyberattacks. The U.S. […]